Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcelina Sperling has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond Obesity: Sex-Specific Associations of Vaspin with Metabolic Dysfunction

    by Marcelina Sperling, Krystyna Czyżewska, Marta Pelczyńska, Paweł Bogdański, Dorota Formanowicz, Edyta Mądry, Teresa Grzelak

    Background: Vaspin (SERPINA12) is an adipokine implicated in the regulation of insulin sensitivity and metabolic homeostasis. Evidence regarding its association with obesity-related metabolic disturbances remains inconsistent, and potential sex-specific differences are not fully understood. Methods: This cross-sectional study included 81 adults aged 30–60 years (38 women and 43 men), divided into a metabolic syndrome group (MS+) and a control group (MS−). Anthropometric, biochemical, total antioxidant status and blood pressure parameters were assessed, and insulin resistance was estimated using the HOMA-IR index. Results: In MS+ men, serum vaspin concentrations were higher than in MS− men (p = 0.004) and were associated with BMI, waist circumference, body fat percentage, fasting insulin, HOMA-IR, and diastolic blood pressure (p < 0.05 for all). In multivariable regression analysis (adjusted for age), insulin levels, lean body mass, and diastolic blood pressure explained up to 15.2% of the variability in serum vaspin concentrations in men (p = 0.035), whereas no significant model was observed in women. ROC (receiver operating characteristic) curve analysis demonstrated better discriminative performance of serum vaspin for identifying metabolic syndrome in men than in women (AUC: 0.784 ± 0.094 vs. 0.416 ± 0.115, respectively; p = 0.013). Conclusions: Circulating vaspin concentrations are more strongly associated with metabolic disturbances in men than in women These findings suggest that sex-specific regulation of vaspin may contribute to differences in metabolic dysfunction associated with visceral obesity. Overall, these results indicate that vaspin may reflect visceral obesity-related metabolic dysfunction rather than general adiposity. Further studies are needed to clarify the mechanistic role of vaspin and to determine whether it has potential as a biomarker of metabolic dysfunction.

  • Open Access

    Concentrations of Glypican-4, Irisin and Total Antioxidant Status in Women with Metabolic Syndrome: Influence of Physical Activity

    by Teresa Grzelak, Marcelina Sperling, Marta Pelczyńska, Aniceta Ada Mikulska-Sauermann, Paweł Bogdański, Krystyna Czyżewska, Edyta Mądry

    Glypican-4 belongs to a group of poorly understood adipokines, with potential importance in people with metabolic syndrome, especially in groups of patients with glucose metabolism disorder. This study aimed to assess the effect of physical activity on serum glypican-4 and irisin levels and total antioxidant status (TAS) in plasma and saliva in women with metabolic syndrome (MetS). Seventy-two Caucasian women aged 25–60 were included in the study (36 women with MetS and 36 women without MetS (control group, CONTR)). The glypican-4 and irisin concentrations, total antioxidant status, glycemia, lipid profile, anthropometric parameters, and blood pressure were analyzed before and after 28 days of controlled physical activity. Serum glypican-4 and plasma TAS levels were higher (p = 0.006 and p = 0.043, respectively) on the 28th day than on the first day of the study only in the CONTR group. In the MetS group, 28 days of physical activity caused a reduction in body fat mass (p = 0.049) without changes in glypican-4, irisin, or TAS levels. In both groups, glypican-4 levels correlated positively with irisin levels and negatively with Waist-Hip Ratio (WHR), while irisin levels correlated positively with High-Density Lipoprotein Cholesterol (HDL-C) levels and negatively with waist circumference (WC) and WHR values on the 28th day of the study. To summarize, a 28-day moderate training, accompanied by a reduction in body fat mass, stabilized glypican-4 levels and TAS in female patients with MetS.


  • Open Access

    Adipolin, Chemerin, Neprilysin and Metabolic Disorders Associated with Obesity

    by Marcelina Sperling, Teresa Grzelak, Marta Pelczyńska, Paweł Bogdański, Krystyna Czyżewska, Dorota Formanowicz

    Adipolin, neprilysin, and chemerin have pleiotropic properties; therefore, their concentrations may influence health complications associated with obesity. The study aimed to search the relationship between adipokine levels and anthropometric and metabolic parameters as well as blood pressure values, taking into account the influence of gender and age. The study group consisted of 88 people aged 30–60 years. It was found that chemerin concentration is positively correlated with glycaemia in the 120′ OGTT (rs = 0.412; p = 0.030) in obese women. There was a negative correlation between adipolin and LDL-C serum concentration (rs = −0.414; p = 0.044) in obese individuals with normal glucose tolerance and a positive correlation between chemerin concentration and triglyceridemia (rs = 0.333; p = 0.033) in the men. Moreover, high chemerin levels (above median values) were observed 3.79 times more frequently (OR = 3.79; 95% CI: 1.03–13.91; p = 0.040) in the male population characterized by elevated triglyceride levels (above 1.7 mmol/L). In the logistic regression analyses, we found that the frequency of high plasma adipolin concentrations increases with age (p = 0.005) only in people with a BMI < 30 kg/m2. It was also shown that the concentrations of the studied adipokines are interrelated. Adipolin, neprilysin and chemerin concentrations are associated with selected anthropometric and metabolism exponents.


  • Open Access

    Association of Serum Omentin-1 Concentration with the Content of Adipose Tissue and Glucose Tolerance in Subjects with Central Obesity

    by Marcelina Sperling, Teresa Grzelak, Marta Pelczyńska, Paweł Bogdański, Dorota Formanowicz, Krystyna Czyżewska

    Omentin is one of the few adipokines with potentially beneficial metabolic effects. The main aim of this study was to determine the association between serum omentin-1 levels and the occurrence of central obesity and abnormal glucose tolerance, taking into account gender. The study involved 88 participants aged 30–60, including 47 women and 41 men. Two subgroups among the obese subjects were distinguished—those with normal and abnormal glucose tolerance. Anthropometric and biochemical examinations and blood pressure measurements were performed. Omentin-1 concentrations were significantly lower among patients with obesity compared to those without obesity (p = 0.027) and, similarly, comparing men with abnormal glucose tolerance with men with normal glucose tolerance (p = 0.035). In contrast, no such pattern was observed in women. The multivariable regression model showed a significant effect of gender status and important factors of tissue insulin sensitivity, such as OGGT results, WHR and amount of body fat, on the variability of serum omentin-1 concentration in the entire study population (R2adj. = 13.7%; p = 0.003). High omentin-1 levels found in men with obesity and normal glucose tolerance suggest that omentin-1 protects against metabolic disorders associated with obesity in the male population.


  • Open Access

    Evaluation of Vitamin D Fractions in Obese Hypertensive Patients

    by Marta Pelczyńska, Teresa Grzelak, Marcelina Sperling, Matylda Kręgielska-Narożna, Paweł Bogdański, Krystyna Czyżewska

    Vitamin D fractions can be involved in the pathogenesis of metabolic disorders, but their concentrations are rarely determined. The aim of this study was to evaluate the concentration of vitamin D fractions in obese hypertensive patients and to determine its associations with anthropometric parameters, glucose levels, and lipid profiles. A total of 85 obese hypertensive patients (OBHT) and 40 nonobese nonhypertensive subjects (NOBNHT) underwent biochemical measurements of lipid profiles, glycemia, 25-hydroxyvitamin D (25(OH)D), free vitamin D (free25(OH)D), vitamin D binding protein, albumin levels. Moreover, free25(OH)D and bioavailable25(OH)D (bio25(OH)D) concentrations were calculated. Blood pressure and anthropometric measurements were performed. Differences between groups (p < 0.001) were found for 25(OH)D (OBHT 40.25 ± 18.02 vs. NOBNHT 64.10 ± 22.29 nmol/L), free25(OH)D (9.77 (7.46; 11.49) vs. 13.80 (10.34; 16.82) pmol/L), bioavailable 25(OH)D (3.7 (2.8; 4.4) vs. 5.4 (4.2; 6.7) nmol/L), and calculated free25(OH)D (7.82 (5.54; 11.64) vs. 10.46(8.06;16.28) pmol/L, p = 0.002). The OBHT patients showed no relationship between vitamin D fractions concentration and glucose or lipids level, although it was associated with anthropometric parameters. In the NOBNHT group, vitamin D fractions correlated positively with HDL cholesterol and negatively with triglyceridemia and hip circumference. Vitamin D fractions were decreased in obese hypertensive subjects, and were associated with anthropometric parameters, but not with glucose level or lipid profiles; they thus cannot be considered as a predictive marker of metabolic disorders in this group of patients.


  • Concentrations of omentin and vaspin versus insulin resistance in obese individuals

    by Marcelina Sperling, Teresa Grzelak, Marta Pelczyńska, Paula Jasinska, Pawel Bogdanski, Danuta Pupek-Musialik, Krystyna Czyzewska